Search
-
Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo
(EClinicalMedicine. vol. 54, 2022-12)Article de revueOpen access -
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
(PLoS Neglected Tropical Diseases. vol. 16, n° 1, 2022-01-06)Article de revueOpen access -
Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France
(Journal of Clinical Virology. vol. 149, 2022-03-15)Article de revueOpen access -
High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea
(IDCases. vol. 27, 2022-02)Article de revueOpen access -
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent
(The Lancet. vol. 401, n° 10378, pp. 789-794, 2023-03-04)Article de revue -
Analysis of the 24-h activity cycle: An illustration examining the association with cognitive function in the Adult Changes in Thought study
(Frontiers in Psychology. vol. 14, 2023-03-27)Article de revueOpen access -
Clinical presentation, outcomes and factors associated with mortality: A prospective study from three COVID-19 referral care centres in West Africa
(International Journal of Infectious Diseases. vol. 108, pp. 45-52, 2021-07)Article de revueOpen access -
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load
(CPT: Pharmacometrics and Systems Pharmacology. vol. 9, n° 9, pp. 509-514, 2020-09)Article de revueOpen access -
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
(PLoS Neglected Tropical Diseases. vol. 14, n° 6, pp. e0008259, 2020)Article de revueOpen access -
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
(EBioMedicine. vol. 74, 2021-11-09)Article de revueOpen access